Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potentialCapsule Summary

Background: The effects of halobetasol propionate (HBP) lotion 0.05% on the hypothalamic-pituitary-adrenal (HPA) axis have not been previously evaluated in adolescents. Objective: To examine the effect of HBP on HPA axis suppression in patients aged <17 years with plaque psoriasis. Methods: In th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vivian Laquer, MD, Andrea Nguyen, PA-C, MS, Nicholas Squittieri, MD, Tien Nguyen, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/9b2fd133847845d3a895f520e3ec634f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!